Literature DB >> 23974995

Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.

Jeffrey D McCurdy1, Edward V Loftus, William J Tremaine, Thomas C Smyrk, David H Bruining, Darrell S Pardi, Laura E Raffals, John B Kisiel, Nayantara Coelho-Prabhu, Sunanda V Kane, William A Faubion, Konstantinos A Papadakis.   

Abstract

BACKGROUND: Up to 30% of cases of pouchitis are felt to have a secondary cause. Cytomegalovirus (CMV) may represent a possible etiopathological agent. Here, we report our experience with CMV involvement of the pouch, including risk factors, clinical features, and pouch outcomes in patients with inflammatory bowel disease after proctocolectomy with ileal pouch-anal anastomosis.
METHODS: The pathology database at Mayo Clinic in Rochester was searched between January 1995 and October 2012 for patients with a tissue diagnosis of CMV of the pouch following ileal pouch-anal anastomosis.
RESULTS: Seven patients with CMV inclusions of the pouch were identified. The median age was 35 (range, 10-53) years, and the majority were female (71%). Five patients (71%) were on immunosuppressive medications including 4 who had undergone orthotopic liver transplantation for primary sclerosing cholangitis. The clinical presentation was similar among all patients: the majority had diarrhea (86%), fever (71%), and abdominal pain (57%). All had mucosal inflammation, with 71% having focal ulcerations in the pouch and 60% having inflammatory changes in the prepouch ileum. All patients improved with ganciclovir. None required pouch excision or had recurrent CMV infection. Three patients had recurrent nonspecific pouchitis.
CONCLUSIONS: A high index of suspicion is needed to diagnose CMV of the pouch. An increase in stool frequency and fever in patients on immune suppression or in those who have failed empiric antibiotics should prompt assessment for CMV infection. Antiviral therapy seems to be effective, and postinfection pouch outcomes seem favorable, particularly in those presenting with their first episode of pouchitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974995      PMCID: PMC4085480          DOI: 10.1097/MIB.0b013e3182a52553

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  43 in total

1.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

Review 2.  Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?

Authors:  Garrett Lawlor; Alan C Moss
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

3.  Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.

Authors:  K A Papadakis; J K Tung; S W Binder; L Y Kam; M T Abreu; S R Targan; E A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

4.  Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients.

Authors:  Willem E Hueting; Erik Buskens; Ingeborg van der Tweel; Hein G Gooszen; Cees J H M van Laarhoven
Journal:  Dig Surg       Date:  2005-04-14       Impact factor: 2.588

5.  Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients.

Authors:  Victor Warren Fazio; Ravi P Kiran; Feza H Remzi; John Calvin Coffey; Helen Mary Heneghan; Hasan Tarik Kirat; Elena Manilich; Bo Shen; Sean T Martin
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

Review 6.  Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts.

Authors:  Polymnia Galiatsatos; Ian Shrier; Esther Lamoureux; Andrew Szilagyi
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

7.  The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study.

Authors:  You Sun Kim; Young-Ho Kim; Joo Sung Kim; Jae Hee Cheon; Byong Duk Ye; Sung-Ae Jung; Young Sook Park; Chang Hwan Choi; Byung Ik Jang; Dong Soo Han; Suk-Kyun Yang; Won Ho Kim
Journal:  J Clin Gastroenterol       Date:  2012-01       Impact factor: 3.062

Review 8.  Secondary pouchitis: those with identifiable etiopathogenetic or triggering factors.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

9.  Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  R F Leal; C S R Coy; M L S Ayrizono; J J Fagundes; M Milanski; M J Saad; L A Velloso; J R N Góes
Journal:  Tech Coloproctol       Date:  2008-05-30       Impact factor: 3.781

Review 10.  Cytomegalovirus infection and the gastrointestinal tract.

Authors:  David M You; Mark D Johnson
Journal:  Curr Gastroenterol Rep       Date:  2012-08
View more
  9 in total

1.  Synchronous cytomegalovirus and Clostridium difficile infection of the pouch: a trigger for chronic pouchitis?

Authors:  Ioannis Papaconstantinou; Evanthia Zampeli; Dionysios Dellaportas; Charalambos Giannopoulos; Maria Sotiropoulou; George Polymeneas; Giorgos Bamias; Spyros Michopoulos
Journal:  Clin J Gastroenterol       Date:  2014-02-14

2.  Update on the pathogenesis and management of pouchitis.

Authors:  Saleem Chowdhry; Jeffry A Katz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 3.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

4.  Cytomegalovirus pouchitis in a patient with Crohn's disease.

Authors:  Nigel Tapiwa Mabvuure; Laura Maclean; Karin Oien; Daniel Gaya
Journal:  BMJ Case Rep       Date:  2014-07-17

Review 5.  Inflammatory pouch disease: The spectrum of pouchitis.

Authors:  Petros Zezos; Fred Saibil
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

6.  Value of routine stool testing for pathogenic bacteria in the evaluation of symptomatic patients with ileal pouches.

Authors:  Amandeep Singh; Jean Ashburn; Gursimran Kochhar; Rocio Lopez; Tracy L Hull; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-11-24

7.  Cytomegalovirus colitis in inflammatory bowel disease and after haematopoietic stem cell transplantation: diagnostic accuracy, predictors, risk factors and disease outcome.

Authors:  Eirini Mavropoulou; Kristin Ternes; Nicolae-Catalin Mechie; Sebastian Christopher Benjamin Bremer; Steffen Kunsch; Volker Ellenrieder; Albrecht Neesse; Ahmad Amanzada
Journal:  BMJ Open Gastroenterol       Date:  2019-02-27

8.  Protracted primary cytomegalovirus infection presenting as ileoanal pouchitis in a non-immunosuppressed patient: a case report.

Authors:  Christian Rupp; Esther Herpel; Paul Schnitzler; Anna Zawierucha; Philipp Zwickel; Lukas Klute; Martina Kadmon; Wolfgang Stremmel; Annika Gauss
Journal:  J Med Case Rep       Date:  2014-05-26

Review 9.  A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis.

Authors:  Zaid S Ardalan; Miles P Sparrow
Journal:  Front Med (Lausanne)       Date:  2020-01-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.